Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fibrinolytic Agents

Known as: thrombolytic drug, [BL115] THROMBOLYTICS, Thrombolytic Drugs 
Any agent capable of dissolving an existing blood clot in order to reperfuse the blocked blood vessel.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
  • C. Borlongan
  • Stem cells translational medicine
  • 2019
  • Corpus ID: 157057922
Four decades of preclinical research demonstrating survival, functional integration, and behavioral effects of transplanted stem… Expand
Review
2019
Review
2019
Stroke is a major cause of morbidity and mortality worldwide. Despite the intensive search for new therapies, hundreds of agents… Expand
Review
2018
Review
2018
As a result of ischemia or hemorrhage, blood supply to neurons is disrupted which subsequently promotes a cas-cade of… Expand
  • table 1
  • table 2
  • table 2
Highly Cited
2008
Highly Cited
2008
2008;133;113-122 Chest Holger J. Schünemann, Deborah Cook and Gordon Guyatt Guidelines (8th Edition) Physicians Evidence-Based… Expand
  • figure 1
  • table 1
  • table 1
Highly Cited
2005
Highly Cited
2005
BACKGROUND A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Review
2004
Review
2004
This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1998
Highly Cited
1998
Summary Background Thrombolysis for acute ischaemic stroke has been investigated in several clinical trials, with variable… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
1993
Highly Cited
1993
BACKGROUND The relative efficacy of streptokinase and tissue plasminogen activator and the roles of intravenous as compared with… Expand
Highly Cited
1987
Highly Cited
1987
Intravenous administration of 80 mg of recombinant tissue plasminogen activator (rt-PA, 40, 20, and 20 mg in successive hours… Expand
  • table 1
  • table 2
  • table 2
  • figure 1
  • figure 2
Highly Cited
1986
Highly Cited
1986
Abstract In an unblinded trial of intravenous streptokinase (SK) in early acute myocardial infarction, 11 806 patients in one… Expand